O. Cohen-Haguenauer, N. Creff, P. Cruz, C. Tunc, A. Aiuti, C. Baum, F. Bosch, P. Blomberg, K. Cichutek, M. Collins, O. Danos, F. Dehaut, M. Federspiel, E. Galun, H. Garritsen, H. Hauser, M. Hildebrandt, D. Klatzmann, O. W. Merten, E. Montini, T. O'Brien, A. Panet, L. Rasooly, D. Scherman, M. Schmidt, M. Schweizer, P. Tiberghien, T. Vandendriessche, H. Ziehr, S. Yla-Herttuala, C. von Kalle, G. Gahrton and M. Carrondo
Dr. Chang obtained a doctorate (Ph.D.) in Microbiology from the University of Iowa, Iowa City. Currently Dr. Chang is a tenured Full Professor in University of Florida College of Medicine, and serves as President of Shenzhen Geno-immune Medical Institute (GIMI), Shenzhen, China. He has published more than 130 scientific publications and filed more than 30 US patents. Dr. Chang develops novel molecular biology and gene therapy tools and participates in individualized medical treatments in multiple clinical trials applying gene and cell based therapeutics.